161 related articles for article (PubMed ID: 36694353)
1. Laboratory testing for mitochondrial diseases: biomarkers for diagnosis and follow-up.
Paredes-Fuentes AJ; Oliva C; Urreizti R; Yubero D; Artuch R
Crit Rev Clin Lab Sci; 2023 Jun; 60(4):270-289. PubMed ID: 36694353
[TBL] [Abstract][Full Text] [Related]
2. Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases.
Trifunov S; Paredes-Fuentes AJ; Badosa C; Codina A; Montoya J; Ruiz-Pesini E; Jou C; Garrabou G; Grau-Junyent JM; Yubero D; Montero R; Muchart J; Ortigoza-Escobar JD; O'Callaghan MM; Nascimento A; Català A; Garcia-Cazorla À; Jimenez-Mallebrera C; Artuch R
Clin Chem; 2021 Aug; 67(8):1113-1121. PubMed ID: 34352085
[TBL] [Abstract][Full Text] [Related]
3. Lipidomic profiling of plasma samples from patients with mitochondrial disease.
Ren C; Liu J; Zhou J; Liang H; Zhu Y; Wang Q; Leng Y; Zhang Z; Yuan Y; Wang Z; Yin Y
Biochem Biophys Res Commun; 2018 Jun; 500(2):124-131. PubMed ID: 29627572
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism.
Liu N; Xiao J; Gijavanekar C; Pappan KL; Glinton KE; Shayota BJ; Kennedy AD; Sun Q; Sutton VR; Elsea SH
JAMA Netw Open; 2021 Jul; 4(7):e2114155. PubMed ID: 34251446
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Biomarkers in the Omics Era: A Clinical-Pathophysiological Perspective.
Gervasoni J; Primiano A; Cicchinelli M; Santucci L; Servidei S; Urbani A; Primiano G; Iavarone F
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732076
[TBL] [Abstract][Full Text] [Related]
6. Monitoring clinical progression with mitochondrial disease biomarkers.
Steele HE; Horvath R; Lyon JJ; Chinnery PF
Brain; 2017 Oct; 140(10):2530-2540. PubMed ID: 28969370
[TBL] [Abstract][Full Text] [Related]
7. Improving post-natal detection of mitochondrial DNA mutations.
Barcia G; Assouline Z; Magen M; Pennisi A; Rötig A; Munnich A; Bonnefont JP; Steffann J
Expert Rev Mol Diagn; 2020 Oct; 20(10):1003-1008. PubMed ID: 32902337
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
[TBL] [Abstract][Full Text] [Related]
9. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and Therapeutic Approaches for Mitochondrial Diseases].
Radelfahr F; Klopstock T
Fortschr Neurol Psychiatr; 2018 Sep; 86(9):584-591. PubMed ID: 30248691
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for mitochondrial energy metabolism diseases.
Boenzi S; Diodato D
Essays Biochem; 2018 Jul; 62(3):443-454. PubMed ID: 29980631
[TBL] [Abstract][Full Text] [Related]
12. Presentation and Diagnostic Evaluation of Mitochondrial Disease.
Dimmock DP; Lawlor MW
Pediatr Clin North Am; 2017 Feb; 64(1):161-171. PubMed ID: 27894442
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for mitochondrial respiratory chain disorders.
Suomalainen A
J Inherit Metab Dis; 2011 Apr; 34(2):277-82. PubMed ID: 20941643
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic approach in infants and children with mitochondrial diseases.
Chi CS
Pediatr Neonatol; 2015 Feb; 56(1):7-18. PubMed ID: 25151629
[TBL] [Abstract][Full Text] [Related]
17. Revisiting mitochondrial diagnostic criteria in the new era of genomics.
Witters P; Saada A; Honzik T; Tesarova M; Kleinle S; Horvath R; Goldstein A; Morava E
Genet Med; 2018 Apr; 20(4):444-451. PubMed ID: 29261183
[TBL] [Abstract][Full Text] [Related]
18. Blood biomarkers of mitochondrial disease-One for all or all for one?
Suomalainen A
Handb Clin Neurol; 2023; 194():251-257. PubMed ID: 36813317
[TBL] [Abstract][Full Text] [Related]
19. Laboratory and metabolic investigations.
Morava E; Oglesbee D
Handb Clin Neurol; 2023; 194():167-172. PubMed ID: 36813311
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
